TipRanks
Go Ultimate55% OFF

Daniel Barber Insider Profile

4 Followers

Daniel Barber, President & CEO, Director at Aquestive Therapeutics, holds 627.32K shares in Aquestive Therapeutics (Ticker: AQST). Most recently, Daniel Barber Sold 25,000 shares of Aquestive Therapeutics on Oct 16, 2026 for an estimated value of $105.50K.

Daniel Barber's Trading History

AQST
Aquestive Therapeutics
Oct 16, 2026President & CEO, DirectorInformative Sell105.50K$2.44M
AQST
Insider Shares: 627.32K (0.50%)
DateTransactionAmountNo. of SharesPrice per ShareProfitLink to Report
Oct 16, 2026Informative Sell$105.50K25,000$4.22-2.90%
Sep 16, 2026Informative Sell$120.25K25,000$4.81+19.20%
Sep 09, 2026Informative Buy$88.07K91,743$0.96-6.40%
Aug 18, 2026Informative Sell$107.00K25,000$4.28-19.20%
Jul 17, 2026Informative Sell$100.14K25,000$4.00-25.00%

You May Also Like

Daniel Barber insider profile FAQ

What is the percentage of profitable transactions made by Daniel Barber?
The percentage of profitable transactions made by Daniel Barber is 30%.
What is the average return per transaction made by Daniel Barber?
The average return per transaction made by Daniel Barber is 16.00%.
What stocks does Daniel Barber hold?
Daniel Barber holds: AQST stocks.
What was Daniel Barber’s latest transaction?
Daniel Barber’s latest transaction was an Informative Sell of $105.50K.
What was Daniel Barber's most profitable transaction?
Daniel Barber’s most profitable transaction was an Informative Buy of AQST stock on June 10, 2022. The return on the trade was 145.60%.
What is Daniel Barber's role in Aquestive Therapeutics?
Daniel Barber's role in Aquestive Therapeutics is President & CEO, Director.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.

TipRanks measures corporate insiders by the stock transactions they report to the SEC. See how TipRanks ranks experts and calculates performance.